Contraceptives, Oral, Synthetic
Mestranol
Contraceptives, Oral
Norgestrel
Contraceptives, Oral, Combined
Norethindrone
Ethynodiol Diacetate
Spermatogenesis-Blocking Agents
Ethinyl Estradiol
Lynestrenol
Contraceptive Agents, Female
Ethinyl Estradiol-Norgestrel Combination
Contraceptives, Oral, Hormonal
Spermatocidal Agents
Contraceptive Agents, Male
Contraceptive Devices
Contraception
Pyridoxine
Menstruation
Riboflavin
Nutrition Disorders
Family Planning Services
Copper
Desogestrel
Levonorgestrel
Contraceptives, Postcoital
Zinc
Pregnancy, Unplanned
Sterilization, Reproductive
Pregnancy
Medroxyprogesterone Acetate
Contraception, Postcoital
Intrauterine Devices, Copper
Norethynodrel
Abortion, Induced
Contraception, Immunologic
Progestins
Norpregnenes
Contraceptives, Oral, Sequential
Contraceptives, Postcoital, Hormonal
Sterilization, Tubal
Fertility
Menstrual Cycle
Health Knowledge, Attitudes, Practice
Parity
Genitalia, Female
Androstenes
Progesterone Congeners
Drug Implants
Megestrol
Sex Education
Contraceptives, Postcoital, Synthetic
Risk Factors
Condoms
Estrogens
Sex Factors
Age Factors
Sex Characteristics
Ovulation Inhibition
Medroxyprogesterone
Norpregnadienes
Transdermal Patch
Estradiol Congeners
Ethisterone
Uterine Hemorrhage
Questionnaires
Metrorrhagia
Condoms, Female
Case-Control Studies
Logistic Models
Nonoxynol
Cross-Sectional Studies
Marriage
Reproductive Health Services
Abortion, Legal
Reproductive History
Provider attitudes toward dispensing emergency contraception in Michigan's Title X programs.(1/444)
(+info)The effects of levonorgestrel implants on vascular endothelial growth factor expression in the endometrium. (2/444)
Vascular endothelial growth factor (VEGF) expression and the microvascular density of the endometrium were studied in Norplant users and normal controls, using immunohistochemistry on formalin-fixed paraffin-embedded endometrial sections. The VEGF staining index was quantified using computerized image analysis. The VEGF staining index between stages of the menstrual cycle and between normal and Norplant endometria were compared. Norplant VEGF staining index was analysed for correlation with microvascular density, duration of Norplant use, the number of bleeding/spotting days in the reference period up to 90 days prior to biopsy, and the length of time since the last bleeding/spotting episode. The results showed that immunoreactive VEGF was detected predominantly in endometrial glands but weakly expressed in the stroma throughout the menstrual cycle, and also in Norplant users. Large variation in the VEGF staining index between individuals was observed and no significant difference in the VEGF staining index was detected between stages of the menstrual cycle for the glands and stroma. The glandular and stromal VEGF staining indices were significantly higher in Norplant than in normal endometrium (P<1x10(-4)). No correlation was found between the Norplant VEGF staining index and endometrial microvascular density, duration of Norplant use, the number of bleeding/spotting days in the reference period, and the length of time since the last bleeding/spotting episode. The VEGF staining index was higher in glands than stroma for both normal and Norplant endometrium. The results suggest a differential control of endometrial glandular versus stromal VEGF expression, and possible positive effects of levonorgestrel on VEGF expression. (+info)Levonorgestrel versus the "Yuzpe" regimen.(3/444)
New choices in emergency contraception. (+info)Three countries' experience with Norplant introduction. (4/444)
Despite international efforts to plan for Norplant introduction, the method has drawn the attention of critics of family planning programmes, and has raised several issues for debate since it was introduced into family planning programmes. The experiences of three countries with the introduction of Norplant highlight some of the unique features of the method that have affected its introduction. Indonesia, Bangladesh and the United States represent diverse cultural settings and systems of family planning provision. Experience in each country has highlighted the need to focus on quality of care for clients, most notably the need for good counselling and attention to removal as well as insertion. The cost of Norplant also has influenced its introduction in each country. Another issue includes the need to work with women's health advocacy groups, which is illustrated particularly in Bangladesh. Finally, the role of litigation in the United States, and its potential role in influencing Norplant introduction in other countries, is discussed. These three countries' experience illustrate the importance of understanding the programmatic context of contraceptive introduction. (+info)Dose linearity study of selegiline pharmacokinetics after oral administration: evidence for strong drug interaction with female sex steroids. (5/444)
AIMS: The purpose of this study was to characterize the dose relationship of selegline and desmethylselegiline pharmacokinetics within the selegiline dose range from 5 to 40 mg. METHODS: Eight female subjects, of whom four were using oral contraceptives, ingested a single dose of 5 mg, 10 mg, 20 mg or 40 mg of selegiline HCl in an open four-period randomized study. Concentrations of selegiline and desmethlylselegiline in serum were measured by gas chromatography for 5 h. As it became evident that the use of oral steroids had a drastic effect on selegiline concentrations, the pharmacokinetic analyses were performed separately for oral contraceptive users and those not receiving any concomitant medication. RESULTS: The total AUC and Cmax of selegiline were 10-to 20-fold higher in those subjects taking oral steroids compared with subjects with no concomitant medication; this finding was consistent and statistically significant at all the four dose levels. The dose linearity of selegiline pharmacokinetics failed to be demonstrated in both groups. The AUC and Cmax of desmethylselegiline were only moderately higher (about 1.5-fold; P=NS at each dose level) in the subjects taking oral steroids than in those not receiving concomitant medication. The AUC values of desmethylselegiline increased in a dose linear manner in subjects with no concomitant medication, but not in the oral steroid group. The metabolic ratio (AUC(desmethylselegiline)/AUC(selegiline)) was several-fold lower in the group receiving oral steroids compared with the no-concomitant-medication group (P<0.005 at all the four dose levels). CONCLUSIONS: Concomitant use of oral contraceptives caused a drastic (20-fold) increase in the oral bioavailability of selegiline. The highly significant difference in the metabolic ratio between the groups provides evidence that the mechanism of the interaction between selegiline and female sex steroids involves reduced T-demethylation of selegiline. The present results suggest that concomitant use of selegiline with exogenous female sex steroids should be avoided or the dosage of selegiline should be reduced in order to minimize the risks of selegiline related adverse drug reactions. (+info)The effect of a levonorgestrel-releasing intrauterine device on human endometrial oestrogen and progesterone receptors after one year of use. (6/444)
Thirty-four women bearing a levonorgestrel-releasing intrauterine device, 20 micrograms/day (LNG-IUD-20), for 12-15 months were recruited. Endometrial biopsies were collected during the late proliferative phase of the cycle (on cycle days 10-12) before (control) and after the use of the IUD for 12 months, and assayed for oestrogen receptors (ER) and progesterone receptors (PR). An immunohistochemical technique with the peroxidase-antiperoxidase detection system (PAP method) was employed. D75 and JZB39 were the primary antibodies for ER and PR respectively. The immunostaining semiquantitative analysis was performed with a computerized microscope image processor, and expressed as 'grey value'. Both endometrial ER and PR populations were significantly lower after insertion of the IUD (P < 0.01) than in control biopsies. The intensity of nuclear staining and the percentage of positively stained cells for ER and PR in women with LNG-IUD were each about 50% of those in control biopsies. The results suggested that LNG released locally from the IUD has a depressive action on the ER and PR, which may contribute to the contraceptive effectiveness of this type of IUD and also to the possible causes of LNG-IUD-induced irregular bleeding and amenorrhoea. (+info)A multicentre efficacy and safety study of the single contraceptive implant Implanon. Implanon Study Group. (7/444)
An open, multicentre study was performed to assess efficacy, safety and acceptability of the single-rod contraceptive implant Implanon. The study involved 635 young healthy women, who were sexually active and of childbearing potential. The women were followed up every 3 months over the entire study period. Originally the study was designed for 2 years, but was extended to 3 years in a group of 147 women from two centres. Altogether, 21 centres in nine different countries participated. The average age of the women was 29 years (range 18-42 years), of whom 83.5% had been pregnant in the past. No pregnancy occurred during treatment with Implanon, resulting in a Pearl Index of 0 (95% confidence interval: 0.0-0.2). In the first 2 years, 31% had discontinued the treatment. Of the 147 women in the study extension, nine discontinued (6%) treatment. Bleeding irregularities was the main reason for discontinuation during the first 2 years of use (17.2%) and adverse experiences in the third year (3.4%). Implant insertion and removal were fast and uncomplicated in the vast majority (97%) of cases. Return of fertility was prompt. In conclusion, Implanon has excellent contraceptive action during its lifetime of 3 years. The safety profile is acceptable and not essentially different from progestogens in general. (+info)Changes in vascular basement membrane in the endometrium of Norplant users. (8/444)
Progestogen-only contraception is almost invariably associated with changes in menstrual bleeding patterns. Changes in the endometrial vasculature, and in particular an increase in vascular fragility, may contribute to this bleeding. In this study, endometrial vascular density and endothelial cell basement membrane components were examined using immunohistochemistry before and after insertion of Norplant. Endometrial vascular density was increased from a mean (+/- SEM) of 189.6 +/- 7.0 vessels/mm2 during the control cycle to 253.9 +/- 80.7 vessels/mm2 at 2-13 weeks of Norplant exposure, and to 212.7 +/- 12.9 vessels/mm2 at 14-42 weeks. During the control cycle, a mean of 161.4 +/- 4.5 vessels/mm2 stained for collagen IV (85% of all vessels), while at 2-13 weeks, 144.5 +/- 13.0 vessels/mm2 stained for collagen IV (57% of all vessels) (t ratio = 2.08, P = 0.0057). By 14-42 weeks, 71% of vessels (151.0 +/- 9.8) vessels/mm2 were surrounded by collagen IV. This was not significantly different from control values (t ratio = 2.03). Endometrial vascular laminin was also reduced following Norplant insertion, from a mean of 176.0 +/- 4.2 vessels/mm2 in the control cycle (93% of vessels), to 156.3 +/- 6.7 vessels/mm2 at 2-13 weeks of exposure (57% of vessels) (t ratio = 2.08, P = 0.01). By 14-42 weeks of exposure to Norplant, 162.5 +/- 9 vessels/mm2 (76%) stained for laminin. This was not significantly different from control values (t ratio = 2.04). Endometrial vascular heparan sulphate proteoglycan (HSPG) was reduced from 58.6 +/- 3.0 vessels/mm2 during the control cycle (31% of vessels) to 43.6 +/- 5.6 vessels/mm2 (only 17% of vessels) at 2-13 weeks (t ratio = 2.08, P = 0.025). At 14-42 weeks, only 19% of vessels stained for HSPG (41.3 +/- 5.8 vessels/mm2; t ratio = 2.04, P = 0.009). (+info)Types of Nutrition Disorders:
1. Malnutrition: This occurs when the body does not receive enough nutrients to maintain proper bodily functions. Malnutrition can be caused by a lack of access to healthy food, digestive problems, or other underlying health issues.
2. Obesity: This is a condition where excess body fat accumulates to the point that it negatively affects health. Obesity can increase the risk of various diseases, such as diabetes, heart disease, and certain types of cancer.
3. Anorexia Nervosa: This is an eating disorder characterized by a fear of gaining weight or becoming obese. People with anorexia nervosa may restrict their food intake to an extreme degree, leading to malnutrition and other health problems.
4. Bulimia Nervosa: This is another eating disorder where individuals engage in binge eating followed by purging or other compensatory behaviors to rid the body of calories consumed. Bulimia nervosa can also lead to malnutrition and other health issues.
5. Diabetes Mellitus: This is a group of metabolic disorders characterized by high blood sugar levels. Type 2 diabetes, in particular, has been linked to poor dietary habits and a lack of physical activity.
6. Cardiovascular Disease: Poor dietary habits and a lack of physical activity can increase the risk of cardiovascular disease, which includes heart disease and stroke.
7. Osteoporosis: A diet low in calcium and vitamin D can contribute to the development of osteoporosis, a condition characterized by brittle bones and an increased risk of fractures.
8. Gout: This is a type of arthritis caused by high levels of uric acid in the blood. A diet rich in purine-containing foods such as red meat, seafood, and certain grains can increase the risk of developing gout.
9. Dental Problems: Poor dietary habits, particularly a diet high in sugar, can contribute to dental problems such as cavities and gum disease.
10. Mental Health Disorders: Malnutrition and other health problems caused by poor dietary habits can also contribute to mental health disorders such as depression and anxiety.
In conclusion, poor dietary habits can have significant negative effects on an individual's overall health and well-being. It is essential to adopt healthy dietary habits such as consuming a balanced diet, limiting processed foods and sugars, and increasing physical activity to maintain good health and prevent chronic diseases.
Also known as: Menstrual Disorders, Menstrual Abnormalities, Dysmenorrhea, Amenorrhea, Oligomenorrhea, Polymenorrhea.
Symptoms of a uterine hemorrhage may include:
* Vaginal bleeding that may be heavy or light in flow
* Pain in the lower abdomen
* Pain during sexual activity
* Spotting or bleeding between menstrual periods
* Unusual discharge from the vagina
If you experience any of these symptoms, it is important to seek medical attention as soon as possible. Uterine hemorrhages can be diagnosed through a physical examination and imaging tests such as ultrasound or MRI. Treatment depends on the underlying cause of the bleeding, but may include medications to control bleeding, surgery to remove fibroids or polyps, or hysterectomy in severe cases.
It is important to note that while uterine hemorrhages can be managed with appropriate medical care, they can also be life-threatening if left untreated. Seeking prompt medical attention and following the advice of your healthcare provider are crucial to preventing complications and ensuring a successful outcome.
Metrorrhagia can be diagnosed through a pelvic exam, ultrasound or hysteroscopy. Treatment options depend on the underlying cause of the condition, and may include medications to regulate hormones or shrink fibroids, or surgery to remove polyps or fibroids. It is important for women who experience metrorrhagia to consult a healthcare provider for proper diagnosis and treatment to rule out any serious underlying conditions such as endometrial cancer.
Word origin: Greek "metro" meaning month + "rhagia" meaning flow.
STDs can cause a range of symptoms, including genital itching, burning during urination, unusual discharge, and painful sex. Some STDs can also lead to long-term health problems, such as infertility, chronic pain, and an increased risk of certain types of cancer.
STDs are usually diagnosed through a physical exam, blood tests, or other diagnostic tests. Treatment for STDs varies depending on the specific infection and can include antibiotics, antiviral medication, or other therapies. It's important to practice safe sex, such as using condoms, to reduce the risk of getting an STD.
Some of the most common STDs include:
* Chlamydia: A bacterial infection that can cause genital itching, burning during urination, and unusual discharge.
* Gonorrhea: A bacterial infection that can cause similar symptoms to chlamydia.
* Syphilis: A bacterial infection that can cause a painless sore on the genitals, followed by a rash and other symptoms.
* Herpes: A viral infection that can cause genital itching, burning during urination, and painful sex.
* HPV: A viral infection that can cause genital warts and increase the risk of cervical cancer.
* HIV/AIDS: A viral infection that can cause a range of symptoms, including fever, fatigue, and weight loss, and can lead to AIDS if left untreated.
It's important to note that some STDs can be spread through non-sexual contact, such as sharing needles or mother-to-child transmission during childbirth. It's also important to know that many STDs can be asymptomatic, meaning you may not have any symptoms even if you are infected.
If you think you may have been exposed to an STD, it's important to get tested as soon as possible. Many STDs can be easily treated with antibiotics or other medications, but if left untreated, they can lead to serious complications and long-term health problems.
It's also important to practice safe sex to reduce the risk of getting an STD. This includes using condoms, as well as getting vaccinated against HPV and Hepatitis B, which are both common causes of STDs.
In addition to getting tested and practicing safe sex, it's important to be aware of your sexual health and the risks associated with sex. This includes being aware of any symptoms you may experience, as well as being aware of your partner's sexual history and any STDs they may have. By being informed and proactive about your sexual health, you can help reduce the risk of getting an STD and maintain good sexual health.
Causes:
There are several possible causes of amenorrhea, including:
1. Hormonal Imbalance: Imbalance of hormones can prevent the uterus from preparing for menstruation.
2. Pregnancy: Pregnancy is one of the most common causes of amenorrhea.
3. Menopause: Women going through menopause may experience amenorrhea due to the decreased levels of estrogen and progesterone.
4. Polycystic Ovary Syndrome (PCOS): PCOS is a hormonal disorder that can cause irregular periods or amenorrhea.
5. Thyroid Disorders: Both hypothyroidism (underactive thyroid) and hyperthyroidism (overactive thyroid) can cause amenorrhea.
6. Obesity: Women who are significantly overweight may experience amenorrhea due to the hormonal imbalance caused by excess body fat.
7. Stress: Chronic stress can disrupt hormone levels and cause amenorrhea.
8. Surgery or Trauma: Certain surgeries, such as hysterectomy or removal of the ovaries, can cause amenorrhea. Trauma, such as a severe injury or infection, can also cause amenorrhea.
9. Medications: Certain medications, such as steroids and chemotherapy drugs, can cause amenorrhea as a side effect.
10. Endocrine Disorders: Disorders such as hypogonadotropic hypogonadism, hyperprolactinemia, and hypothyroidism can cause amenorrhea.
Symptoms:
Amenorrhea can cause a range of symptoms, including:
1. No menstrual period
2. Difficulty getting pregnant (infertility)
3. Abnormal vaginal bleeding or spotting
4. Painful intercourse
5. Weight gain or loss
6. Mood changes, such as anxiety or depression
7. Fatigue
8. Headaches
9. Insomnia
10. Hot flashes
Diagnosis:
Amenorrhea is typically diagnosed based on a patient's medical history and physical examination. Additional tests may be ordered to determine the underlying cause of amenorrhea, such as:
1. Blood tests to measure hormone levels, including estrogen, progesterone, and thyroid-stimulating hormone (TSH)
2. Imaging tests, such as ultrasound or MRI, to evaluate the ovaries and uterus
3. Laparoscopy, a minimally invasive procedure that allows the doctor to visually examine the ovaries and fallopian tubes
4. Hysteroscopy, a procedure that allows the doctor to examine the inside of the uterus
Treatment:
The treatment of amenorrhea depends on the underlying cause. Some common treatments include:
1. Hormone replacement therapy (HRT) to restore hormone balance and promote menstruation
2. Medications to stimulate ovulation, such as clomiphene citrate or letrozole
3. Surgery to remove fibroids, cysts, or other structural abnormalities that may be contributing to amenorrhea
4. Infertility treatments, such as in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), if the patient is experiencing difficulty getting pregnant
5. Lifestyle changes, such as weight loss or exercise, to improve overall health and promote menstruation
Prevention:
There is no specific way to prevent amenorrhea, but maintaining a healthy lifestyle and managing any underlying medical conditions can help reduce the risk of developing the condition. Some tips for prevention include:
1. Eating a balanced diet that includes plenty of fruits, vegetables, whole grains, and lean protein sources
2. Exercising regularly to maintain a healthy weight and improve overall health
3. Managing stress through relaxation techniques, such as yoga or meditation
4. Getting enough sleep each night
5. Avoiding excessive alcohol consumption and smoking
6. Maintaining a healthy body mass index (BMI) to reduce the risk of developing hormonal imbalances
7. Managing any underlying medical conditions, such as polycystic ovary syndrome (PCOS), thyroid disorders, or adrenal gland disorders
8. Avoiding exposure to harmful chemicals and toxins that can disrupt hormone balance.
Levonorgestrel butanoate
Norethisterone
Uric acid
Ethel Byrne
Fania Mindell
Gonadotropin-releasing hormone antagonist
A. Albert Yuzpe
Acrosin
Selective androgen receptor modulator
Vagina
Major depressive disorder
Thalidomide
Effects and aftermath of rape
Follicular atresia
Endometriosis and infertility
Vaginal yeast infection
Estradiol (medication)
Estrone (medication)
Estradiol dipropionate
Gemfibrozil
Polycystic ovary syndrome
Siva Chinnatamby
EC586
Endometrioma
Ulipristal acetate
Endometriosis
Estradiol valerate
Hydroxyprogesterone acetate
Combined injectable birth control
July 1920
Eunice Blanchard Poethig
Cervical cancer
Black genocide
Childbirth
Progestogen ester
Allylestrenol
Norgesterone
Androgen
List of landmark court decisions in the United States
Alkaline phosphatase
Catholic Church
Transgender hormone therapy
Pharmaceutical industry
List of types of killing
Vaccine hesitancy
Sexual and reproductive health
Charlie Baker
List of Ig Nobel Prize winners
List of The Hitchhiker's Guide to the Galaxy characters
Microbicides for sexually transmitted diseases
Scott Brown (politician)
Vaginal flora
Cholestasis
Metformin
Etynodiol diacetate
Endometrial cancer
Dyslipidemia
Valproate
Bodu Bala Sena
Epilepsy and Seizures Treatment & Management: Approach Considerations, Anticonvulsant Therapy, Anticonvulsants for Specific...
Results of search for 'su:{Contraceptive agents, Female.}'
›
WHO HQ Library catalog
ATSDR Hair Analysis Panel Discussion: Appendix D
Zinc: MedlinePlus Supplements
Toxic-Shock Syndrome and the Vaginal Contraceptive Sponge
Dermatologic Manifestations of Hirsutism Medication: Antihypertensives, Antiandrogens, Dermatologic agents, Glucocorticoids,...
British Lung Foundation - Steroid treatment for lungs | Best Lungs | Home Page Blog
Oral Contraceptives Offer Long-Term Protection Against Ovarian Cancer
WHO EMRO | Some aspects of the use of oral contraceptives as growth-promoting agents in poultry | Volume 1, issue 2 | EMHJ...
Incidence of Sexually Transmitted Infections Before and After Insertion of an Intrauterine Device or Contraceptive Implant,...
DeCS
What is considered day 1 of period?
Search | VHL CLAP/WR-PAHO/WHO
DailyMed - TRI-SPRINTEC- norgestimate and ethinyl estradiol kit
Publikasi Scopus FKUI 2021 per tanggal 30 April 2021 (299 artikel)
Search | African Index Medicus (AIM)
Reproductive Health's Link to Heart Disease - MedicineNet Health News
September 2019
Melasma | Medicalalgorithms.com
Contraceptives postcoital synthetic. Medical search
Thrombophilia FAQs | Clotting Frequently Asked Questions
Sarah Pitts, M.D. | Harvard Catalyst Profiles | Harvard Catalyst
Is it okay to eat fried chicken on your period? - Cooking for everyone and everyone
What age do periods stop?
Yanit, K. E.<...
Contraceptive Agents - Physicians for Life
ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer - Full Text View - ClinicalTrials.gov
Von Willebrand Disease Overview: Causes, Effects and Management Strategies.
Pregnancy16
- In women that are 4 months pregnant, starting to take riboflavin by mouth does reduce the risk of pre-eclampsia during pregnancy. (medlineplus.gov)
- If a woman becomes HIV positive during pregnancy, her infant is at risk of becoming infected with HIV. (nih.gov)
- Research supported by NICHD's Pregnancy and Perinatology Branch (PPB) has included studies of BV in pregnant women. (nih.gov)
- The aim of this study was to investigate whether maternal risk for GDM was influenced by type of contraceptive method used before pregnancy. (cdc.gov)
- Nevertheless, no studies have investigated the effects of hormonal contraceptive use before pregnancy and the risk for GDM. (cdc.gov)
- The Missouri Pregnancy Risk Assessment Monitoring System (PRAMS) is an ongoing, population-based survey designed to identify and monitor select maternal experiences, attitudes, and behaviors that occur before, during, and shortly after pregnancy among women delivering a live infant. (cdc.gov)
- Data from PRAMS can be used to determine whether a relationship exists between a woman's contraceptive use before pregnancy and the development of GDM. (cdc.gov)
- Seizure frequency may change during pregnancy, seizures may cause pregnancy complications, and the treatment of a woman with epilepsy must consider all these issues. (who.int)
- Women who use insemination to attempt pregnancy should be cautioned about the possibility of acquiring sexually transmitted diseases from donated body fluids. (aafp.org)
- Vulnerability to ovarian cancer may be increased because of low pregnancy rates and reduced exposure to oral contraceptive agents. (aafp.org)
- Women also can opt for a surgical procedure that permanently prevents pregnancy. (nih.gov)
- 3. Negative beta-HCG pregnancy test for females presumed to be of reproductive potential. (nih.gov)
- Means of postcoital intervention to avoid pregnancy, such as the administration of POSTCOITAL CONTRACEPTIVES to prevent FERTILIZATION of an egg or implantation of a fertilized egg (OVUM IMPLANTATION). (lookformedical.com)
- Unintended accidental pregnancy, including pregnancy resulting from failed contraceptive measures. (lookformedical.com)
- In fact, women who have thrombophilia may have an increased tendency to express symptoms due to the contributing effects of pregnancy or use of hormonal agents (including oral contraceptives). (ihtc.org)
- Emergency contraception is a method of preventing unwanted pregnancy resulting from unintended sexual activity, contraceptive failure or sexual assault, 1 as well as from a lack of knowledge about or access to contraception. (scielo.org.za)
Exposure to oral contraceptive1
- It has been suggested that this tumour might develop in women after long-term exposure to oral contraceptive steroids, although this association has not yet been reported. (nih.gov)
Estrogens3
- This review of the action of estrogens and progestagens, the steroids in oral contraceptives, on cells in the endometrium, breast, ovary, cervix and other tissues, regarding possible causative role in cancer development focuses on the level of steroid receptors and observed actions of these hormones on the cellular level. (nih.gov)
- 8. Relationship of estrogens and oral contraceptives to endometrial cancer in animals and women. (nih.gov)
- 18. Estrogens in oral contraceptives: historical perspectives. (nih.gov)
Levonorgestrel1
- Clinical, pharmacological and epidemiological studies on a levonorgestrel implant contraceptive / by Biran Affandi. (who.int)
Steroids8
- We present here the clinical and pathological findings in a 42-year-old woman who died of hepatic angiosarcoma after taking oral contraceptive steroids for 10 years. (nih.gov)
- This case reports a possible association between HAS and oral contraceptive steroids. (nih.gov)
- 12. Problems in evaluating chronic toxicity of contraceptive steroids in dogs. (nih.gov)
- Feeding chickens with oral contraceptive steroids at the dose used by some poultry growers in Egypt has led to the formation of high estrogen residues in the muscles and the liver compared with controls. (who.int)
- It is concluded that the use of oral contraceptive steroids in chickens as anabolic agent is a specific risk to chickens and probably to the consumer. (who.int)
- Oral contraceptive steroids have been used at excessively high doses as growth-promoting agents by some poultry growers in Egypt. (who.int)
- The purpose of this study is to assess the formation of residues in the muscle and liver of chickens of contraceptive steroids applied orally at the same dose used by poultry growers and the resultant level of estrogen in chickens. (who.int)
- These are actually absolutely nothing to perform along with anabolic steroids (made use of unlawfully through some physical body home builders as well as additionally expert sportsmens) in addition to women hormone representatives (like those made use of in the contraceptive pill as well as hormonal agent substitute treatment). (lunguk.org)
Norplant4
- Norplant : contraceptive subdermal implants, manual for clinicians. (who.int)
- Norplant : contraceptive subdermal implants : guide to effective counseling. (who.int)
- Norplant contraceptive subdermal implants : managerial and technical guidelines. (who.int)
- contraceptive pills, Norplant, or Depo-Provera (and is not on any medications that would interfere with the effectiveness of these contraceptive agents). (nih.gov)
Hormonal contraceptive5
- RH096 trade name] is an oral combined hormonal contraceptive (CHC) agent for women. (who.int)
- Of the 2,741 women who completed the 2007-2008 PRAMS survey, 8.3% were diagnosed with gestational diabetes, and 17.9% of the respondents had used hormonal contraceptive methods. (cdc.gov)
- However, little is known about hormonal contraceptive use and its role in the development of gestational diabetes (GDM). (cdc.gov)
- Likewise, Diab and Zaki found that fasting blood glucose was higher among users of oral contraceptives and Depo-Provera (depot-medroxyprogesterone acetate, DMPA), a progestogen-only reversible hormonal contraceptive injected every 3 months (9). (cdc.gov)
- There was no association between heart disease risk and current use of progesterone -only contraceptives, use of non-oral hormonal contraceptive agents or fertility treatment, the study authors noted. (medicinenet.com)
Endometrium1
- 9. The development of adenocarcinoma of the endometrium in young women receiving long-term sequential oral contraception. (nih.gov)
20181
- Between 1 Jan. 2015 and 31 Dec. 2018, 18,691 service women in the study population received an intrauterine device (IUD) and 17,723 received an implant. (health.mil)
Progesterone2
- Use of skeletally active agents such as bisphosphonates, teriparatide, SERMS, hormone replacement therapy and progesterone-only contraceptive agents (combination oral contraceptive use in premenopausal women is not an exclusion criterion). (nih.gov)
- A synthetic progestational agent with actions similar to those of PROGESTERONE. (lookformedical.com)
19781
- The following is testimony presented on behalf of the National Women's Health Network, at the March 8, 1978, Hearings on Contraceptive Research before the Select Committee on Population of the U.S. House of Representatives. (scienceforthepeople.org)
Neoplasia1
- 10. Oral contraceptives and neoplasia. (nih.gov)
Long-acting rev1
- Long-acting reversible contraceptive (LARC) use, including subdermal hormonal implants and intrauterine devices (IUDs), has been increasing for almost 2 decades, from 1.5-2.5% of U.S. women of childbearing age in the early 2000s 1,2 to 10.3-14.3% between 2009 and 2015. (health.mil)
Endometrial cancer4
- 1. Incidence of endometrial cancer in relation to the use of oral contraceptives. (nih.gov)
- 2. Oral contraceptives and endometrial cancer. (nih.gov)
- 11. Decreased risk of endometrial cancer among oral-contraceptive users. (nih.gov)
- It can also be a sign of endometrial cancer, which affects 2 to 3% of women and is most common among postmenopausal women. (lacocinadegisele.com)
Cervical2
- Little is known about transmission of human immunodeficiency virus (HIV) infection during lesbian sexual activity, but woman-to-woman transmission has been documented, and the virus has been isolated from menstrual fluid, cervical biopsies and vaginal secretions. (aafp.org)
- Examples of such safer methods include the cervical cap, diaphragm, contraceptive sponge, ovulation method and thermal sperm control. (scienceforthepeople.org)
Progestational2
- Tri-Sprintec ® (norgestimate and ethinyl estradiol tablets USP) is a combination oral contraceptive containing the progestational compound norgestimate, USP and the estrogenic compound ethinyl estradiol, USP. (nih.gov)
- A synthetic progestational hormone used often as the progestogenic component of combined oral contraceptive agents. (lookformedical.com)
Orally2
- Fixed drug combinations administered orally for contraceptive purposes. (lookformedical.com)
- It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES. (lookformedical.com)
Oral contraception1
- 6. Endometrial abnormalities occurring in young women on long-term sequential oral contraception. (nih.gov)
Preterm birth1
- A major focus of the Network's research has been on the ability of antibiotics, including clindamycin and metronidazole, to prevent preterm birth in pregnant women who test positive for BV but have no symptoms. (nih.gov)
Ovarian4
- Oral contraceptives are often the initial treatment for hirsutism caused by ovarian hyperandrogenism and idiopathic hirsutism. (medscape.com)
- This article is intended for primary care clinicians, obstetrician-gynecologists, oncologists, and other specialists who care for women at risk for ovarian cancer. (medscape.com)
- Describe the effects of oral contraceptives on the risk for ovarian cancer. (medscape.com)
- The female vaccinee has no reproductive potential because of menopause (1 year without menses) or because of a hysterectomy, bilateral oophorectomy, medically-documented ovarian failure, or tubal ligation. (nih.gov)
Implant3
- Choice and challenge : global teamwork in developing a contraceptive implant. (who.int)
- Among active component service women who received an IUD or implant and maintained the same marital status during the study period, there was no notable increase in incidence of STIs in the 12 months after LARC insertion when compared to the 12 months before insertion. (health.mil)
- In general, among service women who began using LARC (an IUD or a contraceptive implant), incidence rates of STIs did not increase from the year before to the year after insertion. (health.mil)
Fertility1
- Women and Epilepsy: Sudanese experience - Safa et a l required for a normal menstrual cycle and Teaching Hospital and El-shiekh Mohamed Kheir fertility. (who.int)
Hormone5
- However, for women there are unique concerns related to hormone effects on seizures and the effects of seizures and antiepileptic drugs (AEDs) on reproductive health. (who.int)
- There are now several hormone and hormone-like agents that can improve the rate of growth and efficiency of feed use of farm animals. (who.int)
- The use of compounds exhibiting sex hormone-like activities as anabolic agents was introduced into agricultural practice about 35 years ago. (who.int)
- While the combination of ethinyl estradiol and norgestimate increases sex hormone binding globulin (SHBG) and decreases free testosterone, the relationship between these changes and a decrease in the severity of facial acne in otherwise healthy women with this skin condition has not been established. (nih.gov)
- First, as you may know, contraceptive research at present focuses heavily on hormones, drugs and invasive devices, such as hormone-releasing IUDs, prostaglandins, injectable progestogens, silastic hormonal skin implants and antipregnancy vaccines. (scienceforthepeople.org)
Diaphragm1
- Also, the intensive education model used with teenage women in some family-planning clinics demonstrates that existing barrier methods, like the diaphragm, are much more effective than previously thought. (scienceforthepeople.org)
Ovulation3
- Norgestrel is used as a contraceptive, ovulation inhibitor, and for the control of menstrual disorders and endometriosis. (lookformedical.com)
- Particularly good examples are the contraceptive sponge, which requires no fitting, and the ovulation method, which requires no mechanical intervention. (scienceforthepeople.org)
- For example, the self-help model used in many women-run health centers improves use-effectiveness of barrier methods as well as the ovulation method. (scienceforthepeople.org)
Efficacy1
- Some AEDs reduce the efficacy of oral contraceptive agents, increasing the probability of unplanned pregnancies. (who.int)
Formulations1
- 16. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. (nih.gov)
Menstrual cycle3
- The menstrual cycle, which is counted from the first day of one period to the first day of the next, isn't the same for every woman. (soflanights.com)
- Abnormal uterine bleeding that is not related to MENSTRUATION, usually in females without regular MENSTRUAL CYCLE. (lookformedical.com)
- For most women this happens every 28 days or so, but it's common for periods to be more or less frequent than this, ranging from day 21 to day 40 of their menstrual cycle. (justcookingclass.com)
Glucocorticoids1
- Use of glucocorticoids for more than 14 days in the past 12 months with the exception of inhaled agents. (nih.gov)
Intrauterine1
- Most-such as birth control pills, vaginal rings, female condoms, and intrauterine devices-rely on the woman. (nih.gov)
Gestational diabetes2
Effectiveness1
- Postcoital contraceptives which owe their effectiveness to hormonal preparations. (lookformedical.com)
Combination5
- For androgen-excess syndromes, such as PCOS, the following medications are used, often in combination with oral contraceptives. (medscape.com)
- Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive use. (nih.gov)
- For this reason, combination oral contraceptives, including Tri-Sprintec ® , should not be used by women who are over 35 years of age and smoke. (nih.gov)
- Combination oral contraceptives act by suppression of gonadotropins. (nih.gov)
- It is used as the estrogen component of many combination ORAL CONTRACEPTIVES. (lookformedical.com)
LARCs2
- as one illustration, NHS3 bisexuals were more than twice as likely to use LARCs (aRR [95% CI]: 2.01 [1.67, 2.42]).While certain sexual minority subgroups (e.g., bisexuals) were more likely than heterosexuals to use contraceptive methods such as LARCs, lesbians were less likely to use any method.Many sexual minority patients need contraceptive counseling and providers should ensure to offer this counseling to patients in need, regardless of sexual orientation. (nih.gov)
- However, LARCs may have an additional appeal to female service members because of the ability of some LARCs to suppress menstruation, 7,8,11 which may be advantageous in military operational environments. (health.mil)
Diabetes1
- Studies have examined the effects of contraception on the metabolisms of women who were previously diagnosed with GDM and found that women using hormonal methods of contraception had a higher risk for type 2 diabetes than did women using nonhormonal contraceptive methods (4). (cdc.gov)
Fetus1
- Recent data suggest that BV may increase the risk of transmission of HIV from a woman to her fetus. (nih.gov)
Premature2
- Menopause that occurs before a woman is in her mid-40s is known as early or premature menopause. (lacocinadegisele.com)
- In cases where insufficient research has resulted in premature approval of contraceptive methods, much larger female populations have been exposed unnecessarily to dangers. (scienceforthepeople.org)
Suppression1
- in women it leads to suppression of oestrogen release from the ovaries . (susans.org)
Doses1
- Oral contraceptives typically have progestin dosages at the plateau of the dose-response curve, but lower estrogen doses may possible improve the cancer risk. (nih.gov)
Complications1
- As a result, symptomatic fibroids lower the quality of life for many Black women by causing pain, compromising the ability to get pregnant, and increasing the likelihood of serious medical complications like anemia. (verywellhealth.com)
Chemical3
- Chemical substances or agents with contraceptive activity in females. (nih.gov)
- C. Drugs, chemical agents, and toxins g. (nih.gov)
- Family medical history, genetics, weight, high blood pressure and cholesterol levels , and chemical imbalances from use of hormonal contraceptives are among the possible explanations for these associations, according to study author Krishnarajah Nirantharakumar, a senior clinical lecturer at the University of Birmingham in the United Kingdom, and colleagues. (medicinenet.com)
Chronic1
- Over the years, concerns have been raised about the possible association between hormonal contraceptives and various chronic diseases, including cardiovascular disease, breast cancer, and metabolic dysfunction. (cdc.gov)
Risk7
- however, much of the research is still unable to reach consensus on the long-term effects of contraceptives and an increased risk for GDM. (cdc.gov)
- After reviewing these studies, we hypothesized that an increased risk for GDM would be observed among women who had used hormonal methods of contraception. (cdc.gov)
- However, findings did show that rates of STIs increased from the LARC pre-insertion period to the post-insertion period among women in the youngest age category, suggesting that risk-reduction counseling and educational efforts should be focused on the youngest service members who receive LARC. (health.mil)
- Sutura b-linch modificada como profilaxis en pacientes con riesgo para hemorragia posparto: serie de casoss / Modified B-Lynch suture as prophylaxis in patients with risk for postpartum haemorrhage. (bvsalud.org)
- This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. (nih.gov)
- For the study, the researchers analyzed 32 reviews that assessed women of childbearing age and their subsequent risk of heart disease . (medicinenet.com)
- Previous research has suggested that women may have specific risk factors for heart disease and stroke , but there were questions about the quality of evidence, the study authors said in a journal news release. (medicinenet.com)
Cohort1
- 95% confidence interval [CI]: 0.10 [0.04, 0.26]) and results were similar for other contraceptive methods and in the NHS3 cohort. (nih.gov)
Methods5
- We used log-binomial models to estimate contraceptive methods ever used across sexual orientation groups and cohorts, adjusting for age and race.Lesbians were the least likely of all sexual orientation groups to use any contraceptive method. (nih.gov)
- Because STIs can negatively affect service members readiness and cause serious medical sequelae, the results of the study suggest that providers should emphasize to younger service women that LARC methods do not protect against STIs. (health.mil)
- At the same time, there is relatively little research on safer and cheaper mechanical and barrier methods, on contraceptives which act locally rather than systemically, or on methods which require no mechanical intervention whatsoever. (scienceforthepeople.org)
- The safer contraceptive methods also tend not to require physician intervention, thus providing low cost, easily accessible birth control for more people. (scienceforthepeople.org)
- Too much emphasis has been, and continues to be, placed on the presumed passivity of women and on the desirability of methods requiring little or no active participation. (scienceforthepeople.org)
Subjects1
- Too often such research has exposed human subjects, mostly women, to serious adverse consequences. (scienceforthepeople.org)
Sperm3
- In the female reproductive tract, sperm use their tails to swim toward the egg. (nih.gov)
- In past work, the scientists studied the sites on EPPIN that are bound by agents that inhibit human sperm motility. (nih.gov)
- Inhibition of sperm motility in male macaques with EP055, a potential non-hormonal male contraceptive. (nih.gov)
Hepatic1
- In addition, monotherapy may be less expensive than polytherapy, as many of the older anticonvulsant agents have hepatic enzyme-inducing properties that decrease the serum level of the concomitant drug, thereby increasing the required dose of the concomitant drug. (medscape.com)
Adult1
- To study the clinical presentation of epilepsy among adult Sudanese females and to verify aspects of epilepsy specific to women. (who.int)
Hormones2
- Abnormalities of sex steroid hormones charity clinic, and to verify aspects of epilepsy may adversely affect cortical excitability in specific to women e.g. persons who have epilepsy. (who.int)
- Il existe aujourd'hui plusieurs hormones et agents de type hormonal qui peuvent améliorer le taux de croissance des animaux d'élevage ainsi que l'efficacité de l'apport alimentaire pour ces animaux. (who.int)
Pregnant5
- NICHD's Maternal-Fetal Medicine Units (MFMU) Network has played a leading role in studying BV in pregnant women, especially those who are asymptomatic. (nih.gov)
- MFMU researchers also conducted a study of maternal markers that could predict the likelihood of preterm delivery in pregnant women with BV. (nih.gov)
- For this reason, it is important to understand and take steps to control BV in pregnant women to help protect their unborn fetuses not only from the effects of BV but also from acquiring HIV/AIDS. (nih.gov)
- Other research supported by NICHD has included studies to identify maternal markers for predicting the likelihood of preterm delivery in pregnant women with BV. (nih.gov)
- No, women in menopause cannot get pregnant. (lacocinadegisele.com)
Adverse2
- Oral contraceptives also help enhance antihirsutism effects and prevent adverse effects of menstrual irregularity caused by spironolactone and other antiandrogen therapy. (medscape.com)
- In addition, adverse consequences of contraceptive drugs and devices account for a surprisingly large number of hospital admissions, which are both expensive and traumatic for the women involved. (scienceforthepeople.org)
Experimental1
- The experimental birds in Group C received contraceptive pills and DMBA at the same dose levels for the same period. (who.int)
Effects1
- A major focus of its studies has been the actual effects of antibiotics, especially clindamycin and metronidazole, in preventing preterm births in women with BV. (nih.gov)
Intervention1
- A similar low proportion of women required surgical intervention in both groups. (nih.gov)
Research6
- Because BV can potentially cause infertility, ongoing research on infertility supported by the NICHD's Contraception Research Branch provides valuable information on the health of women affected by BV. (nih.gov)
- 20. [The present state of research on the relationship of oral contraceptives to breast cancer]. (nih.gov)
- Research conducted by Visser et al compared hormonal and nonhormonal contraceptive use by diabetic women and found that high-dose oral contraceptives impaired glucose homeostasis (8). (cdc.gov)
- Broad objectives are to: o Enhance domestic population research programs through training and international collaborative studies related to population, including the study of reproductive processes, contraceptive development, contraceptive and reproductive evaluation, reproductive epidemiology, and social and behavioral factors that influence population dynamics. (nih.gov)
- It is alarming to note that in 1976 out of $70 million spent worldwide on contraceptive research outside of the drug industry, only $50,000 was spent on barrier method research. (scienceforthepeople.org)
- We believe that this problem of noncompliance exists in the narrower area of contraceptive drug research. (scienceforthepeople.org)
Researchers2
Condoms1
- condoms, male or female, with a spermicide. (nih.gov)